Publications
74
Citations
387
Est. group size
~8
Recurring co-author estimate
Active years
14
Publishing since 2013
Benjamin D. Liu's research focuses on digestive system disorders, particularly gastroesophageal reflux disease (GERD), esophageal conditions, and gut motility problems, with a strong emphasis on large population-based studies using global health databases. Much of the recent work examines how newer diabetes and weight-loss medications (GLP-1 receptor agonists) affect the digestive system, including risks like bacterial overgrowth and reflux symptoms. The work combines large retrospective data analyses with clinical studies on esophageal function testing.
Publication output was minimal before 2020 but has grown substantially since, with a sharp increase starting in 2023 and sustained high output through 2025, indicating a strongly growing and currently very active publication record.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Association of Body Mass Index With Disorders of Gut-Brain Interaction: A Large Global Population-Based Analysis
The American Journal of Gastroenterology · 2026
- How Are Pregnant Patients With Irritable Bowel Syndrome or Functional Dyspepsia Managed Pharmacologically? A Cross‐Sectional Study Using a Global Database
Neurogastroenterology & Motility · 2026
- Short‐Term Daily Vonoprazan Treatment Is More Commonly Associated With Infectious Gastroenteritis Than Short‐Term Daily PPI Treatment
Neurogastroenterology & Motility · 2026
- Glucagon-like Peptide-1 Receptor Agonists Are Associated With Improved Survival and Reduced Liver-Related Events in Patients With Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease: A Large Real-World Retrospective Study
Endocrine Practice · 2025
- Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis
Diagnostics · 2025
- Some Risks of Gastrointestinal Adverse Events Associated With Glucagon‐Like PEPTIDE‐1 Receptor Agonists Are Likely Explained by BMI
Alimentary Pharmacology & Therapeutics · 2025
- The Impact of Socioeconomic Metrics on the Outcomes of Endovascular Treatment of Aortic Dissection: A Mediation Analysis
Journal of Vascular Surgery · 2025
- Gastroesophageal Reflux Disease and Related Conditions Are Associated With Increased Risk for Nontuberculous Mycobacterium Infection
Journal of Clinical Gastroenterology · 2025
- Su1320: COMPARISON OF INCIDENCE AND PREVALENCE OF BARRETT’S ESOPHAGUS AMONG SEX AND RACIAL/ETHNIC GROUPS: A POPULATION-BASED ANALYSIS USING A GLOBAL DATASET
Gastroenterology · 2025
- Sa1107: INTERIM RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS OF GASTROESOPHAGEAL REFLUX DISEASE AND GASTROINTESTINAL MOTILITY RELEVANT SYMPTOMS IN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST-BASED RANDOMIZED CONTROLLED TRIALS.
Gastroenterology · 2025
- Su1353: GASTROESOPHAGEAL REFLUX EPISODES DURING THE SLEEP PERIOD ARE STRONGLY ASSOCIATED WITH LIMB MOVEMENT
Gastroenterology · 2025
- Su1354: TIME SERIES ANALYSIS REVEALS SIGNIFICANT CHANGES IN NOCTURNAL IMPEDANCE DUE TO AWAKENINGS FROM SLEEP
Gastroenterology · 2025
- Tu1693: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RA) AND COMBINED GLP-1 RA + GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE THERAPY IS ASSOCIATED WITH DEVELOPING SMALL INTESTINAL BOWEL OVERGROWTH WITHIN A YEAR
Gastroenterology · 2025
- Outcomes of unibody endoprosthesis for treatment of aortic aneurysmal pathology and aortoiliac occlusive disease
Vascular · 2025
- Progressive Increase in Small Intestinal Bacterial Overgrowth Risk Following COVID-19 Infection: A Global Population-Based Study
Diseases · 2025
- Gastroenterology×15
- The American Journal of Gastroenterology×13
- Neurogastroenterology & Motility×4
- Gut×3
- International Journal of Medical Students×3
- Frederick W. Woodley
Medicine · The Ohio State University
- Stefanie Rohde
Medicine · The Ohio State University
- Kyle A. Perry
Medicine · The Ohio State University
- Kathryn A. Hasenstab
Medicine · The Ohio State University
- Sudarshan R. Jadcherla
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile